Systematic Evaluation of a Tissue-engineered Bone for Maxillary Sinus Augmentation in Large Animal Canine Model
Overview
Authors
Affiliations
The objective of this study is to systematically evaluate the effects of a tissue-engineered bone complex for maxillary sinus augmentation in a canine model. Twelve sinus floor augmentation surgeries in 6 animals were performed bilaterally and randomly repaired with the following 3 groups of grafts: group A consisted of tissue-engineered osteoblasts/beta-TCP complex (n=4); group B consisted of beta-TCP alone (n=4); group C consisted of autogenous bone obtained from iliac crest as a positive control (n=4). All dogs had uneventful healings following the surgery. Sequential polychrome fluorescent labeling, maxillofacial CT, microhardness tests, as well as histological and histomorphometric analyses indicated that the tissue-engineered osteoblasts/beta-TCP complex dramatically promoted bone formation and mineralization and maximally maintained the height and volume of elevated maxillary sinus. By comparison, both control groups of beta-TCP or autologous iliac bone showed considerable resorption and replacement by fibrous or fatty tissue. We thus conclude that beta-TCP alone could barely maintain the height and volume of the elevated sinus floor, and that the transplantation of autogenous osteoblasts on beta-TCP could promote earlier bone formation and mineralization, maximally maintain height, volume and increase the compressive strength of augmented maxillary sinus. This tissue engineered bone complex might be a better alternative to autologous bone for the clinical edentulous maxillary sinus augmentation.
Purbantoro S, Taephatthanasagon T, Purwaningrum M, Hirankanokchot T, Peralta S, Fiani N Front Vet Sci. 2024; 11:1325559.
PMID: 38450027 PMC: 10915013. DOI: 10.3389/fvets.2024.1325559.
Structural insights into the binding of zoledronic acid with RANKL computational simulations.
Wang R, Zhang W, Ma H, Zou D, Zhang Z, Wang S Front Mol Biosci. 2022; 9:992473.
PMID: 36200071 PMC: 9527314. DOI: 10.3389/fmolb.2022.992473.
A Novel Bone Substitute Based on Recombinant Type I Collagen for Reconstruction of Alveolar Cleft.
Ito M, Toriumi T, Hiratsuka T, Imura H, Akiyama Y, Chimedtseren I Materials (Basel). 2021; 14(9).
PMID: 33946797 PMC: 8125289. DOI: 10.3390/ma14092306.
Jin Q, Li P, Yuan K, Zhao F, Zhu X, Zhang P J Tissue Eng. 2020; 11:2041731420975569.
PMID: 33312494 PMC: 7716067. DOI: 10.1177/2041731420975569.
Endothelial progenitor cells with stem cells enhance osteogenic efficacy.
Li Q, Yu T, Wang F, Liu X, Wang Z Am J Transl Res. 2020; 12(6):2409-2424.
PMID: 32655780 PMC: 7344071.